A Pilot Peer Mentor Intervention That Trains Black Men Who Have Sex With Men (BMSM) to Use and Promote Uptake of HIV/STI Self-Testing to Peers and Sex Partners: STAR Study (Self-Testing at Your Residence) (STAR)
Pilot Peer Mentor Intervention to Train Black MSM to Use and Promote Home-based HIV and STI Testing
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Lighthouse Studies @ Peer Point
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- self-report male sex
- condomless anal sex with >1 male in the prior 6 months
- self-report Black race
- aged 18 or older
- internet use at least once a week.
Exclusion Criteria:
- younger than 17
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Peer Mentor
Peer Mentor Training is 5 individual sessions with a 30 day check-in session.
This condition is focused on training Index with communication skills to promote HIV and STI testing and treatment and pre-exposure prophalaxis (PrEP) to individuals in their social networks.
Peer Mentor training is conducted by a one health educator.
The sessions are held once a week and will last approximately 60 minutes.
|
Participants will be trained to be Peer Mentors and promote home-based testing to their social network
|
|
Active Comparator: Control
Is one individual-based session which will be conducted by sending a video about the website of a health educator.
|
Participants will be given instructions on how to use the project website to request kits to test for HIV at home and collect specimens for lab testing.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Session Attendance
Time Frame: 3 month
|
number of participants who completed 80%
|
3 month
|
|
Number of Index Participants Who Requested Test Kits
Time Frame: 3 months
|
Number of Index participants who requested test kits is reported
|
3 months
|
|
Number of Participants Who Return Kits for Testing
Time Frame: 3 month
|
Number of participants who returned kits to lab for testing is reported.
|
3 month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Willingness and intention to initiate pre-exposure prophalaxis (PrEP)
Time Frame: baseline and 3 month
|
Assessment of changes to willingness and intention to initiate PrEP
|
baseline and 3 month
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Karin E Tobin, PhD, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1R34MH118178 (U.S. NIH Grant/Contract)
- IRB00009216 (Other Identifier: JHSPH IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.